Then, on January 14, 2025, ICON issued financial guidance for 2025 that came in well below analysts' expectations which the company attributed to the downturn in the industry. This news caused the ...

New York, New York-- (Newsfile Corp. - February 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain ...

Singer Liam Gallagher has addressed the circumstances around the crackdown on Oasis tickets by taking to Twitter, recently ...

The Subaru Forester is entering the next generation. With a sharper design, greater comfort and more safety, the sixth ...

The way forward is by matching the pace at which consumer needs evolve—and there is a great opportunity for products to ...

For those who curate and present Black history in Palm Beach County, the effort to erase their past is hardly new. It goes ...

Formula 1 broadcasting legend Martin Brundle has made a startling admission about his famous grid walk interviews, describing ...

Just FYI, BuzzFeed and its publishing partners may collect a share of sales and/or other compensation from the links on this ...

The Outlaw Music Festival, is coming to the Hollywood Bowl this May as part of their 10th anniversary tour. Willie Nelson and ...

Anheuser-Busch’s CEO wants to market its beer as “American made,” rather than  “domestic”—the term that typically differentiates U.S. beer from ...

Grammy-winning R&B icon Toni Braxton ... of equal or greater value will be awarded. Prize elements may not be separated. Availability of the prize is contingent on the live performance element. Should ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.